Evidence map›Paper›PMID 34073389›Full record

ArticleInternational journal of molecular sciences2021

Kawasaki Disease Patient Stratification and Pathway Analysis Based on Host Transcriptomic and Proteomic Profiles.

Heather Jackson, Stephanie Menikou, Shea Hamilton, Andrew McArdle, Chisato Shimizu, Rachel Galassini, Honglei Huang, Jihoon Kim, Adriana Tremoulet, Adam Thorne and 10 more

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
2.7field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 20 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Review
  10. The Future of Kawasaki Disease Diagnosis: Liquid Biopsy May Hold the Key.International journal of molecular sciences · 2024
    Review
  11. The etiologies of Kawasaki disease.The Journal of clinical investigation · 2024
    Review
  12. Article
  13. Article
  14. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors at 7 institutions in 3 countries.

Heather JacksonFaculty of Medicine, Imperial College London, London SW7 2AZ, UK.ORCID 0000-0002-1054-9983
Stephanie MenikouFaculty of Medicine, Imperial College London, London SW7 2AZ, UK.
Shea HamiltonFaculty of Medicine, Imperial College London, London SW7 2AZ, UK.ORCID 0000-0001-6308-0253
Andrew McArdleFaculty of Medicine, Imperial College London, London SW7 2AZ, UK.
Chisato ShimizuDepartment of Pediatrics, University of California San Diego, La Jolla, CA 92093, USA.
Rachel GalassiniFaculty of Medicine, Imperial College London, London SW7 2AZ, UK.ORCID 0000-0002-1025-0367
Honglei HuangTarget Discovery Institute, University of Oxford, Oxford OX3 7FZ, UK.
Jihoon KimDepartment of Biomedical Informatics, University of California San Diego, La Jolla, CA 92093, USA.
Adriana TremouletDepartment of Pediatrics, University of California San Diego, La Jolla, CA 92093, USA.
Adam ThorneDepartment of Surgery, Section of Hepatobiliary Surgery and Liver Transplantation, University of Groningen, University Medical Center Groningen, 9713 GZ Groningen, The Netherlands.
Roman FischerDiscovery Proteomics Facility, Target Discovery Institute, Nuffield Department of Medicine, University of Oxford, Oxford OX3 9DU, UK.
Marien I de JongeSection Pediatric Infectious Diseases, Laboratory of Medical Immunology, Radboud Institute for Molecular Life Sciences, Radboud University Medical Center, 6525 GA Nijmegen, The Netherlands.
Taco KuijpersDepartment of Pediatric Immunology, Rheumatology, and Infectious Diseases, Emma Children's Hospital, Amsterdam University Medical Center (AMC), 1105 AZ Amsterdam, The Netherlands.
Victoria WrightFaculty of Medicine, Imperial College London, London SW7 2AZ, UK.ORCID 0000-0001-7826-1516
Jane C BurnsDepartment of Pediatrics, University of California San Diego, La Jolla, CA 92093, USA.
Climent Casals-PascualWellcome Trust Centre for Human Genetics, University of Oxford, Oxford OX3 7BN, UK.
Jethro HerbergFaculty of Medicine, Imperial College London, London SW7 2AZ, UK.ORCID 0000-0001-6941-6491
Mike LevinFaculty of Medicine, Imperial College London, London SW7 2AZ, UK.ORCID 0000-0003-2767-6919
Myrsini KaforouFaculty of Medicine, Imperial College London, London SW7 2AZ, UK.ORCID 0000-0001-9878-4007
On Behalf Of The Perform Consortium
Imperial College London · GBUniversity of California San Diego · USUniversity of Oxford · GBCentre for Human Genetics · GBEmma Kinderziekenhuis · NLRadboud University Nijmegen · NLUniversity Medical Center Groningen · NL

Funding

Innate Immune Activation and Endothelial Cell Dysfunction in Acute Kawasaki DiseaseR01HL140898 · NHLBI · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI BURNS, JANE C, HOFFMAN, HAROLD M · 2018 to 2022
$4.3M
Horizon 2020 668303NHLBI NIH HHS RO1HL140898Seventh Framework Programme 279185Wellcome Trust 206508/Z/17/ZWellcome Trust 215214/Z/19/Z
6 · The paper itself

Abstract

The aetiology of Kawasaki disease (KD), an acute inflammatory disorder of childhood, remains unknown despite various triggers of KD having been proposed. Host 'omic profiles offer insights into the host response to infection and inflammation, with the interrogation of multiple 'omic levels in parallel providing a more comprehensive picture. We used differential abundance analysis, pathway analysis, clustering, and classification techniques to explore whether the host response in KD is more similar to the response to bacterial or viral infections at the transcriptomic and proteomic levels through comparison of 'omic profiles from children with KD to those with bacterial and viral infections. Pathways activated in patients with KD included those involved in anti-viral and anti-bacterial responses. Unsupervised clustering showed that the majority of KD patients clustered with bacterial patients on both 'omic levels, whilst application of diagnostic signatures specific for bacterial and viral infections revealed that many transcriptomic KD samples had low probabilities of having bacterial or viral infections, suggesting that KD may be triggered by a different process not typical of either common bacterial or viral infections. Clustering based on the transcriptomic and proteomic responses during KD revealed three clusters of KD patients on both 'omic levels, suggesting heterogeneity within the inflammatory response during KD. The observed heterogeneity may reflect differences in the host response to a common trigger, or variation dependent on different triggers of the condition.

Indexed as

Bacterial InfectionsGene Expression ProfilingMucocutaneous Lymph Node SyndromeProteomicsVirus DiseasesAdolescentChildChild, PreschoolComputational BiologyFemaleHumansMaleclassificationclusteringhost ‘omicsinfectious diseasesKawasaki diseasepaediatricspathway analysisproteomicssystems biologytranscriptomics

Identifiers

PMID34073389
PMCPMC8198135
OpenAlexW3165733786

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.